News

Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...
Trump has again threatened the multibillion-dollar pharmaceutical sector with high tariffs unless they move production to the U.S.
President Trump announced potential tariffs on imported pharmaceuticals by month's end, followed by semiconductor levies.
Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.
The country’s biggest pharmaceuticals group pointed to “specific non-allied countries” and urged the White House to ...
Trump’s latest two industrial sector tariffs—200 percent on pharmaceuticals and 50 percent on copper—have serious ...